Cambodia Scraps Drug Export Tendering
Cambodia is to award a three-year monopoly for exclusive import of drugs and medical equipment used by the Ministry of Health to the Doung Chivv Import-Export Tourism and Transport Co, reports the Phnom Penh Post. The government has thus scrapped the competitive bidding system for drug imports which it introduced in 1995.
Health Under-Secretary Nuth Sokhom said it was the Prime Minister's decision to end tendering due to delays, sometimes as long as 60 weeks, in getting tenders approved and goods delivered, and that the Ministry had been working to overcome these delays.
The Ministry has set a budget of 12 billion riel ($4.8 million) for medical purchases in 1996, reports the Phnom Penh Post.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze